RAPPOLD HOERBRAND GUDRUN has a total of 14 patent applications. Its first patent ever was published in 1997. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Czechia. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are WELL RESOURCES LTD, AMRAD OPERATIONS PTY LTD and ANCHOR THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Czechia | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Hungary | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Norway | 1 | |
#9 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Rappold-Hoerbrand Gudrun | 10 |
#2 | Rao Ercole | 10 |
#3 | Haecker Beate | 1 |
#4 | Rappold-Hoerbrand Gudrun Prof | 1 |
#5 | Rao Ercole Dr | 1 |
Publication | Filing date | Title |
---|---|---|
EP1583554A2 | Use of natriuretic peptides for the treatment of stature disorders related to the shox gene | |
WO0134181A2 | Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene | |
WO0058461A1 | Gene for ataxia | |
KR20000048838A | Human growth gene and short stature gene region |